InvestorsHub Logo

justdafactss

01/30/21 7:57 PM

#143600 RE: moneycrew #143588

Leronlimab Administration
Leronlimab 700 mg was administered via 2 abdominal subcutaneous injections of 350 mg each, with repeat dosing if they remained hospitalized after 7 days. All treatment decisions and laboratory monitoring were left to the discretion of the physicians caring for the patients.

2 (two) not 4 (four) correct?
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1583/5932277

Patients will be randomized to receive weekly doses of 700 mg leronlimab (PRO 140), or placebo.
https://clinicaltrials.gov/ct2/show/record/NCT04347239?term=leronlimab&draw=2&rank=5

Starting at 45:30 mark---
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1583/5932277